BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nord HJ. Biopsy diagnosis of cirrhosis: Blind percutaneous versus guided direct vision techniques--a review. Gastrointest Endosc. 1982;28:102-104. [PMID: 6211383 DOI: 10.1016/s0016-5107(82)73015-9] [Cited by in Crossref: 97] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Cheng Z, Lv Y, Pang S, Bai R, Wang M, Lin S, Xu T, Spalding D, Habib N, Xu R. Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis. Acta Pharm Sin B 2015;5:194-200. [PMID: 26579446 DOI: 10.1016/j.apsb.2015.02.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
2 Yu J, He JQ, Chen DY, Pan QL, Yang JF, Cao HC, Li LJ. Dynamic changes of key metabolites during liver fibrosis in rats. World J Gastroenterol 2019;25:941-54. [PMID: 30833800 DOI: 10.3748/wjg.v25.i8.941] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, Mohammadkani A, Derakhshan MH, Zamani F, Samiee S, Malekzadeh R. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol 2005;5:32. [PMID: 16221307 DOI: 10.1186/1471-230X-5-32] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
4 Ozkurt H, Keskiner F, Karatag O, Alkim C, Erturk SM, Basak M. Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol 2014;11:e3555. [PMID: 24693297 DOI: 10.5812/iranjradiol.3555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
5 Meng N, Gao X, Yan W, Wang M, Liu P, Lu XD, Zhang SJ, Lu YQ, Tang WX. Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses. J Huazhong Univ Sci Technolog Med Sci. 2015;35:230-234. [PMID: 25877357 DOI: 10.1007/s11596-015-1416-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
6 Salas JR, Chen BY, Wong A, Duarte S, Angarita SAK, Lipshutz GS, Witte ON, Clark PM. Noninvasive Imaging of Drug-Induced Liver Injury with 18F-DFA PET. J Nucl Med 2018;59:1308-15. [PMID: 29496991 DOI: 10.2967/jnumed.117.206961] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 de Bruyn G, Graviss EA. A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis. BMC Med Inform Decis Mak 2001;1:6. [PMID: 11806763 DOI: 10.1186/1472-6947-1-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li T, Che-Nordin N, Wáng YXJ, Rong PF, Qiu SW, Zhang SW, Zhang P, Jiang YF, Chevallier O, Zhao F, Xiao XY, Wang W. Intravoxel incoherent motion derived liver perfusion/diffusion readouts can be reliable biomarker for the detection of viral hepatitis B induced liver fibrosis. Quant Imaging Med Surg 2019;9:371-85. [PMID: 31032185 DOI: 10.21037/qims.2019.02.11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
9 Blomley MJ, Lim AK, Harvey CJ, Patel N, Eckersley RJ, Basilico R, Heckemann R, Urbank A, Cosgrove DO, Taylor-Robinson SD. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Gut. 2003;52:1188-1193. [PMID: 12865280 DOI: 10.1136/gut.52.8.1188] [Cited by in Crossref: 96] [Cited by in F6Publishing: 79] [Article Influence: 5.3] [Reference Citation Analysis]
10 Hoefs J, Chang K, Wang F, Kanel G, Morgan T, Braunstein P. Perfused Kupffer cell mass. Correlation with histology and severity of chronic liver disease. Dig Dis Sci 1995;40:552-60. [PMID: 7895543 DOI: 10.1007/BF02064368] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 Wietzke-Braun P, Braun F, Schott P, Ramadori G. Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection? World J Gastroenterol 2003;9:745-50. [PMID: 12679924 DOI: 10.3748/wjg.v9.i4.745] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
12 Kim YW, Kwon JH, Jang JW, Kim MJ, Oh BS, Chung KW, Park ES, Nam SW. Diagnostic usefulness of real-time elastography for liver fibrosis in chronic viral hepatitis B and C. Gastroenterol Res Pract 2014;2014:210407. [PMID: 25180031 DOI: 10.1155/2014/210407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
13 Shen L, Li JQ, Zeng MD, Lu LG, Fan ST, Bao H. Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis. World J Gastroenterol. 2006;12:1292-1295. [PMID: 16534888 DOI: 10.3748/wjg.v12.i8.1292] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
14 Schöniger-Hekele M, Müller C. The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis. Dig Dis Sci 2006;51:338-45. [PMID: 16534678 DOI: 10.1007/s10620-006-3135-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
15 Lim AK, Taylor-Robinson SD, Patel N, Eckersley RJ, Goldin RD, Hamilton G, Foster GR, Thomas HC, Cosgrove DO, Blomley MJ. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut. 2005;54:128-133. [PMID: 15591518 DOI: 10.1136/gut.2003.030965] [Cited by in Crossref: 106] [Cited by in F6Publishing: 89] [Article Influence: 6.6] [Reference Citation Analysis]
16 Corbin IR, Buist R, Peeling J, Zhang M, Uhanova J, Minuk GY. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut. 2003;52:1046-1053. [PMID: 12801965 DOI: 10.1136/gut.52.7.1046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]